This report, from Stratview Research, studies the global lung cancer prognosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
Oncologists are increasingly prescribing targeted drugs for tumour with specific molecular aberrations such as inhibitors of changed or amplified proteins such as EGFR or ALK in lung cancer. Among other trends, increased use of antibody (replacing) than chemotherapy, is revolutionizing the treatment of lung cancer. These paradigm shifts in treatment is changing the overall way Lung cancer is treated in the developed markets.
The study identifies the shift behind shift of lung cancer surgery in elderly patients and female patients, and a decrease in the proportion of patients requiring extensive pulmonary resection. Stages of lung cancer can help a doctor identify the best course of treatment, hence it is important to study the market from diagnostics and surgical procedures used to treat this condition. There are several tests to detect the stage and spread of the condition including biopsy, Imaging scans (PET, CT), Lung Function Test (Spirometry). The study gives insight on the population that requires surgery and looks at the population which are treated with medicines, depending on the metastasis.
Tyrosine-kinase inhibitors (TKIs) are gradually becoming the most popular option for lung cancer treatment in China. While in the developed markets such as the USA, cancer is no longer a single tumour type diagnosis but is defined by a combination of factors, including histology and biomarker status. The variation in treatment and requirement of surgery or just medication impacts all the stakeholders in the market who are attached as diagnostic equipment, surgical equipment, pharmaceutical or any support services, across the globe.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The Global Lung Cancer Prognosis Market is segmented into the following categories:
By Treatment Algorithm
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In the case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
Opportunities & Gaps in the Asia-Pacific In Vitro Diagnostics Market - by Products & Services (Equipment, Reagents, Services, other), by Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematolo..
Opportunities & Gaps in the American IVD Market - by Products & Services (Equipment, Reagents, Services, other), by Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, others), by Thera..
Opportunities & Gaps in the European In Vitro Diagnostic Market - By Products & Services (Reagents & Kits, Equipment, New Technology/Connect Laboratories (AI in lab), Data Management Services, Laboratory Supp..
Opportunities and Gaps in The Global Life Sciences Reagents Segment in the Clinical Laboratories Market
Opportunities & Gaps in the Allergy Diagnostics Market: By Products (Assay Kits, Immunoassay & Elisa Analysers, Illuminometers, and Others), By Allergens (Food, Inhaled, Drug), By Type of Test (In Vivo, In Vitro)..
Opportunities & Gaps in the Laboratory Glassware Market: By Product Type (Glass Pipettes and Pipette Tips, Glass Storage Containers, Glass Flasks, Glass Beakers, Glass Petri Dishes, Glass Burettes, Other Glassware), ..
Opportunities & Gaps in the Global Laboratory Equipment Services Market: By Type of Services (Repair, Calibration, Validation, Feedback on Usage), by Service Provider Type (OEM, Distributor, and Third Party), by Type..
Opportunities & Gaps in the Global Clinical Laboratory Filtration Market: By Technology (Ultrafiltration, Microfiltration, Nano-filtration, and Reverse Osmosis), By After Sales Services (Calibration, Repair, and Vali..
Opportunities & Gaps in the Global Laboratory Information System (LIS) Market: By Type (Broad-based LIMS, Industry-specific LIMS), by Component (Services & Software), By Deployment (On Site, Remote Access and Clo..